| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | Director | President
2 companies
Nash Duane is an Executive Chairman at IMUX, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 12 sales. Those positions are worth an estimated $344K at current prices.
Our model assigns Nash Duane a below-average insider score of 27/100, based on 4 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -57.6%.
Nash Duane's largest disclosed position is in AKBA as Director, worth about $314K. The recent filings there lean toward selling, a net 14,093 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | IMUX Immunic, Inc. | Executive Chairman | Buy | 20,000 | $0.83 | $16,694.00 | +124.8% | +5.9% | - | |
| May 12, 2022 | IMUX Immunic, Inc. | Executive Chairman | Buy | 10,000 | $5.03 | $50,300.00 | +83.1% | -0.2% | -66.2% | |
| Aug 10, 2021 | IMUX Immunic, Inc. | Executive Chairman | Buy | 1,000 | $9.80 | $9,800.00 | +7.1% | +1.3% | -47.4% | |
| May 12, 2021 | IMUX Immunic, Inc. | Executive Chairman | Buy | 4,000 | $12.75 | $51,000.00 | +39.9% | -22.4% | -59.2% | |
| Dec 4, 2019 | IMUX Immunic, Inc. | Director | Sale+OE | 4,400 | $6.96 | $30,624.00 | -30.5% | - | - | |
| Feb 15, 2018 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 1,000 | $14.62 | $14,620.00 | -4.4% | - | - | |
| Oct 2, 2017 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 1,188 | $19.64 | $23,332.32 | -5.0% | - | - | |
| Jul 3, 2017 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 990 | $14.27 | $14,127.30 | -4.0% | - | - | |
| Jun 8, 2017 | IMUX Immunic, Inc. | President | Buy | 3,900 | $3.12 | $12,182.04 | +90.2% | - | - | |
| Apr 3, 2017 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 991 | $9.20 | $9,119.28 | -3.9% | - | - |